{"commentary":{"count":22,"free_build_floor":8,"listing_floor":3,"by_channel":{"x_thread":11,"youtube":6,"podcast":3,"x_video":2},"note":"Indexed podcasts, YouTube videos and X posts that name this trial. A report screens them, searches for more and cites what clinicians said when it is built."},"free_build":{"available":true,"how":"POST https://www.erudio.com/api/trial-requests with {\"nct_id\": \"NCT05896566\", \"email\": \"<work email>\"}. The person who owns that inbox must confirm by the emailed link; agents cannot confirm. The result is the report's public preview; the full report is still bought."},"name":"PREcoopERA","nct_id":"NCT05896566","offer":{"currency":"USD","how":"Order at https://www.erudio.com/contact?report=precoopera-nct05896566. The price is fixed at order. We build the report after the order and deliver it when it passes our checks; if it cannot be built to our standard, nothing is charged.","price_usd":1250,"size":"standard","size_rule":"Standard: 13–40 commentary sources"},"registry":{"acronym":"PREcoopERA","arms":[{"description":"Giredestrant","label":"Arm A: Giredestrant","type":"EXPERIMENTAL"},{"description":"Giredestrant plus triptorelin","label":"Arm B: Giredestrant plus triptorelin","type":"EXPERIMENTAL"},{"description":"Anastrozole plus triptorelin","label":"Arm C: Anastrozole plus triptorelin","type":"ACTIVE_COMPARATOR"}],"collaborators":["Hoffmann-La Roche"],"completion_date":{"date":"2025-09-18","type":"ACTUAL"},"conditions":["Breast Cancer"],"enrollment":{"count":231,"type":"ACTUAL"},"has_results":false,"interventions":[{"name":"Giredestrant","type":"DRUG"},{"name":"Triptorelin","type":"DRUG"},{"name":"Anastrozole","type":"DRUG"}],"last_update":"2026-02-24","lead_sponsor":"ETOP IBCSG Partners Foundation","official_title":"A Window-of-Opportunity Trial of Giredestrant +/- Triptorelin vs. Anastrozole + Triptorelin in Premenopausal Patients With ER-positive/HER2-negative Early Breast Cancer","overall_status":"COMPLETED","phases":["PHASE2"],"primary_completion_date":{"date":"2025-09-18","type":"ACTUAL"},"primary_outcomes":[{"measure":"Change in Ki 67","timeFrame":"From date of randomisation until 29 ±3 days post-randomisation"}],"references":[],"start_date":{"date":"2024-01-23","type":"ACTUAL"},"study_type":"INTERVENTIONAL","title":"A Window-of-Opportunity Trial of Giredestrant +/- Triptorelin vs. Anastrozole + Triptorelin in Premenopausal Patients With ER-positive/HER2-negative Early Breast Cancer","url":"https://clinicaltrials.gov/study/NCT05896566"},"report":null,"schema_id":"erudio.trial_listing","schema_version":"2.0","state":"listed","state_text":"No report yet. It can be ordered.","url":"https://www.erudio.com/trials/precoopera-nct05896566"}